HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Experimental treatment of bilateral fetal chylothorax using in-utero pleurodesis.

AbstractOBJECTIVE:
To assess the use and efficacy of in-utero pleurodesis for experimental treatment of bilateral fetal chylothorax.
METHODS:
This was a study of 78 fetuses with bilateral pleural effusion referred to three tertiary referral centers in Taiwan between 2005 and 2009. Fetuses were karyotyped following amniocentesis and the lymphocyte ratio in the pleural effusion was determined following thoracocentesis. Forty-nine (62.8%) fetuses had a normal karyotype and were recognized to have fetal chylothorax; of these, 45 underwent intrapleural injection of 0.1KE OK-432 per side per treatment. We evaluated clinical (hydrops vs. no hydrops) and genetic (mutations in the reported lymphedema-associated loci: VEGFR3, PTPN11, FOXC2, ITGA9) parameters, as well as treatment outcome. Long-term survival was defined as survival to 1 year of age.
RESULTS:
The overall long-term survival rate (LSR) was 35.6% (16/45); the LSR for non-hydropic fetuses was 66.7% (12/18) and for hydropic fetuses it was 14.8% (4/27). If we included only fetuses with onset of the condition in the second trimester, excluding those with onset in the third trimester, the LSR decreased to 29.4% (10/34). Notably, 29.6% (8/27) of hydropic fetuses had mutations in three of the four loci examined.
CONCLUSIONS:
OK-432 pleurodesis appeared to be an experimental alternative to the gold-standard technique of thoracoamniotic shunting in non-hydropic fetal chylothorax. In hydropic fetuses, pleurodesis appeared less effective.
AuthorsY-S Yang, G-C Ma, J-C Shih, C-P Chen, C-H Chou, K-T Yeh, S-J Kuo, T-H Chen, W-L Hwu, T-H Lee, M Chen
JournalUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology (Ultrasound Obstet Gynecol) Vol. 39 Issue 1 Pg. 56-62 (Jan 2012) ISSN: 1469-0705 [Electronic] England
PMID21584887 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2011 ISUOG. Published by John Wiley & Sons, Ltd.
Chemical References
  • Picibanil
Topics
  • Amniocentesis
  • Chylothorax (diagnostic imaging, genetics, mortality, therapy)
  • Female
  • Fetal Diseases (diagnostic imaging, genetics, mortality, therapy)
  • Humans
  • Hydrops Fetalis (diagnostic imaging, genetics, mortality, therapy)
  • Karyotyping
  • Picibanil (administration & dosage)
  • Pleural Effusion (diagnostic imaging, genetics, mortality, therapy)
  • Pleurodesis (methods)
  • Pregnancy
  • Prognosis
  • Survival Rate
  • Taiwan (epidemiology)
  • Ultrasonography, Prenatal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: